Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
La Revue De Medecine Interne
|
January 1, 1996
[Hypophyseal adenomas: functional and tumor evaluation and therapeutic approaches]
D Tielmans, M Assayag, M Virally-Monod, et al.
Neurosurgery
|
October 8, 1997
A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas. French Multicenter Octreotide Study Group
A Warnet, A G Harris, E Renard, et al.
The New England Journal of Medicine
|
July 2, 1987
Visual improvement with SMS 201-995 in a patient with a thyrotropin-secreting pituitary adenoma
P J Guillausseau, P Chanson, J Timsit, et al.
Acta Endocrinologica
|
April 1, 1991
Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995)
A Warnet, E Lajeunie, F Gelbert, et al.
Annales De Medecine Interne
|
January 1, 1982
[Gonadotropic adenoma]
A Warnet, J Lubetzki, J Gueris, et al.
Annales De Medecine Interne
|
January 1, 1991
[Isolated corticotropin insufficiency, disclosed by hyponatremia, and associated with hypothyroidism]
S Ledoux, P Birman, P Chanson, et al.
Clinical Endocrinology
|
March 1, 1993
Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumour volume in men
N Lahlou, E Le Nestour, P Chanson, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
January 1, 1991
Short-term continuous infusion of octreotide in acromegaly. Pharmacokinetics and prediction of the response to long-term treatment
J Timsit, P Chanson, A G Harris, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1992
Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions
J Bertherat, T Brue, A Enjalbert, et al.
Journal of Endocrinological Investigation
|
February 1, 1994
Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas
P Chanson, N Lahlou, A Warnet, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
La Revue De Medecine Interne
|
January 1, 1996
[Hypophyseal adenomas: functional and tumor evaluation and therapeutic approaches]
D Tielmans, M Assayag, M Virally-Monod, et al.
Neurosurgery
|
October 8, 1997
A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas. French Multicenter Octreotide Study Group
A Warnet, A G Harris, E Renard, et al.
The New England Journal of Medicine
|
July 2, 1987
Visual improvement with SMS 201-995 in a patient with a thyrotropin-secreting pituitary adenoma
P J Guillausseau, P Chanson, J Timsit, et al.
Acta Endocrinologica
|
April 1, 1991
Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995)
A Warnet, E Lajeunie, F Gelbert, et al.
Annales De Medecine Interne
|
January 1, 1982
[Gonadotropic adenoma]
A Warnet, J Lubetzki, J Gueris, et al.
Annales De Medecine Interne
|
January 1, 1991
[Isolated corticotropin insufficiency, disclosed by hyponatremia, and associated with hypothyroidism]
S Ledoux, P Birman, P Chanson, et al.
Clinical Endocrinology
|
March 1, 1993
Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumour volume in men
N Lahlou, E Le Nestour, P Chanson, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
January 1, 1991
Short-term continuous infusion of octreotide in acromegaly. Pharmacokinetics and prediction of the response to long-term treatment
J Timsit, P Chanson, A G Harris, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1992
Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions
J Bertherat, T Brue, A Enjalbert, et al.
Journal of Endocrinological Investigation
|
February 1, 1994
Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas
P Chanson, N Lahlou, A Warnet, et al.
Page
of 8